GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) » Definitions » EV-to-EBIT

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) EV-to-EBIT : 7.74 (As of May. 28, 2025)


View and export this data going back to 2007. Start your Free Trial

What is PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Enterprise Value is MAD768.1 Mil. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was MAD99.2 Mil. Therefore, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT for today is 7.74.

The historical rank and industry rank for PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT or its related term are showing as below:

CAS:PRO' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.31   Med: 9.04   Max: 17.7
Current: 7.74

During the past 9 years, the highest EV-to-EBIT of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM was 17.70. The lowest was 6.31. And the median was 9.04.

CAS:PRO's EV-to-EBIT is ranked better than
82.63% of 691 companies
in the Drug Manufacturers industry
Industry Median: 16.75 vs CAS:PRO: 7.74

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Enterprise Value for the quarter that ended in Dec. 2024 was MAD832.0 Mil. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was MAD99.2 Mil. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 11.92%.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM EV-to-EBIT Historical Data

The historical data trend for PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM EV-to-EBIT Chart

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only 6.31 9.08 8.15 10.29 8.39

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.15 - 10.29 - 8.39

Competitive Comparison of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT falls into.


;
;

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM EV-to-EBIT Calculation

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=768.106/99.195
=7.74

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's current Enterprise Value is MAD768.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was MAD99.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM  (CAS:PRO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=99.195/831.971
=11.92 %

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Enterprise Value for the quarter that ended in Dec. 2024 was MAD832.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was MAD99.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Business Description

Traded in Other Exchanges
N/A
Address
Rue N 7, ZI du Sahel, BP 96/97, Berrechid, Had Soualem, MAR, 26400
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM is engaged in production, marketing, import and export of pharmaceuticals, parapharmaceuticals, dermopharmaceuticals and cosmetics.